Revolver Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $762K

  • Investors
  • 7

Revolver Therapeutics General Information

Description

Developer of peptide-based drug discovery technology designed to identify and develop next-generation therapeutics for cancer treatment. The company's platform utilizes patented constrained peptide screening technology to rapidly evaluate millions of peptide candidates and identify functional inhibitors targeting transcription factors, enabling pharmaceutical researchers and oncology-focused drug development organizations to access novel therapeutic compounds that address previously undruggable cancer targets through a more efficient and targeted discovery process.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Innovation Centre University Of Bath Claverton Down
  • Bath BA2 7AY
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Innovation Centre University Of Bath Claverton Down
  • Bath BA2 7AY
  • England, United Kingdom

Revolver Therapeutics Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revolver Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 06-Jul-2026 $762K Completed Generating Revenue
3. Seed Round 15-Nov-2024 Completed Generating Revenue
2. Grant 28-Aug-2024 $712K Completed Generating Revenue
1. University Spin-Out 08-Feb-2023 Completed Generating Revenue
To view Revolver Therapeutics’s complete valuation and funding history, request access »

Revolver Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Revolver Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Revolver Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revolver Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
QantX Venture Capital Minority
Future Planet Capital Venture Capital Minority
O2h Ventures Venture Capital Minority
UK Innovation & Science Seed Fund Venture Capital Minority
Innovate UK Government
You’re viewing 5 of 7 investors. Get the full list »

Revolver Therapeutics FAQs

  • When was Revolver Therapeutics founded?

    Revolver Therapeutics was founded in 2023.

  • Where is Revolver Therapeutics headquartered?

    Revolver Therapeutics is headquartered in Bath, United Kingdom.

  • What is the size of Revolver Therapeutics?

    Revolver Therapeutics has 4 total employees.

  • What industry is Revolver Therapeutics in?

    Revolver Therapeutics’s primary industry is Drug Discovery.

  • Is Revolver Therapeutics a private or public company?

    Revolver Therapeutics is a Private company.

  • What is the current valuation of Revolver Therapeutics?

    The current valuation of Revolver Therapeutics is .

  • What is Revolver Therapeutics’s current revenue?

    The current revenue for Revolver Therapeutics is .

  • How much funding has Revolver Therapeutics raised over time?

    Revolver Therapeutics has raised $956K.

  • Who are Revolver Therapeutics’s investors?

    QantX, Future Planet Capital, O2h Ventures, UK Innovation & Science Seed Fund, and Innovate UK are 5 of 7 investors who have invested in Revolver Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process